Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic ; volume:31 ; number:11 ; day:12 ; month:8 ; year:2024 ; pages:7562-7568 ; date:10.2024
Annals of surgical oncology ; 31, Heft 11 (12.8.2024), 7562-7568, 10.2024
- Urheber
-
Khorfan, Rhami
Vora, Halley P.
Namm, Jukes P.
Solomon, Naveenraj L.
Lum, Sharon S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-024-15787-8
- URN
-
urn:nbn:de:101:1-2412202107002.873573373668
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.0007, 06:30 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khorfan, Rhami
- Vora, Halley P.
- Namm, Jukes P.
- Solomon, Naveenraj L.
- Lum, Sharon S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
Multidisciplinary Approach to Neoadjuvant Endocrine Therapy in Breast Cancer: A Comprehensive Review
Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study
Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy
Indications
Indications
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
Multidisciplinary Approach to Neoadjuvant Endocrine Therapy in Breast Cancer: A Comprehensive Review
Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study
Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy
Indications
Indications
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
Multidisciplinary Approach to Neoadjuvant Endocrine Therapy in Breast Cancer: A Comprehensive Review
Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study
Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy
Indications
Indications